‹ ›
MYP_032373
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Standard
23 amino acids
C120H187N41O32S2
Standard
Sequence
GRRRRSVQWCAVSQPEATKCFQW
Physicochemical Analysis
2780.15 Da
10.72
3.74
3.51
0.1627
-0.97
0.25
-0.34
127.69
33.91
0.1304
11000.00
11125.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1227.19
-13.69
47.0
38.0
89.0
195.0
6.0
25.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0087994 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 13.0%, E 0.0%, T 52.2%, C 34.8% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0161525 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Lactoferrin-derived
9606;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Hepatitis B virus (Virus entry); HepaRG
80 %
RT-PCR
PaperCharacterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide. | Florian PE, Macovei A, Lazar C, Milac AL, Sokolowska I, Darie CC, Evans RW, Roseanu A, Branza-Nichita N. | J Med Virol. 2013 | PMID:23508903 PMID23508903 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/23508903/